← Open Payments lookup

JENNIFER FORSTALL: Open Payments

NPI 1144993437 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,811 in 98 payments from 12 companies in 2025. Trend: 2023 $896 · 2024 $1,474 · 2025 $4,811

Food & beverage: $2,567Travel & lodging: $1,605Honoraria: $640
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc19$2,734
Gilead Sciences, Inc.34$901
Madrigal Pharmaceuticals21$386
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$311
Janssen Scientific Affairs, LLC1$139
Intercept Pharmaceuticals, Inc.5$78
ABBVIE INC.1$77
Veloxis Pharmaceuticals, Inc.3$70
Novo Nordisk Inc3$50
Takeda Pharmaceuticals U.S.A., Inc.1$26

Products named: IQIRVO, REZDIFFRA, XIFAXAN, OCALIVA, LINZESS, ENVARSUS, Wegovy, LIVTENCITY.

Industry payments across LA — which companies pay providers there.